0001847837-21-000001.txt : 20210303 0001847837-21-000001.hdr.sgml : 20210303 20210303152635 ACCESSION NUMBER: 0001847837-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 EFFECTIVENESS DATE: 20210303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Asylia Therapeutics, Inc. CENTRAL INDEX KEY: 0001847837 IRS NUMBER: 842626885 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391131 FILM NUMBER: 21708685 BUSINESS ADDRESS: STREET 1: 3139 W HOLCOMBE BLVD STREET 2: SUITE 445 CITY: HOUSTON STATE: TX ZIP: 77025 BUSINESS PHONE: 617-921-9645 MAIL ADDRESS: STREET 1: 3139 W HOLCOMBE BLVD STREET 2: SUITE 445 CITY: HOUSTON STATE: TX ZIP: 77025 D 1 primary_doc.xml X0708 D LIVE 0001847837 Asylia Therapeutics, Inc. 3139 W HOLCOMBE BLVD SUITE 445 HOUSTON TX TEXAS 77025 617-921-9645 DELAWARE None None Corporation true 2019 Elan Ezickson 3139 W Holcombe Boulevard Suite 445 Houston TX TEXAS 77025 Executive Officer Director Joseph Kekst 3139 W Holcombe Boulevard Suite 445 Houston TX TEXAS 77025 Director Jeno Gyuris 3139 W Holcombe Boulevard Suite 445 Houston TX TEXAS 77025 Executive Officer Director Biotechnology Decline to Disclose 06b false 2021-02-16 false true false 0 16193628 8193628 8000000 false 1 0 0 0 false Asylia Therapeutics, Inc. /s/ Elan Ezickson Elan Ezickson President 2021-03-03